4.5 Letter

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

Journal

BLOOD CANCER JOURNAL
Volume 12, Issue 5, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-022-00676-8

Keywords

-

Funding

  1. European Union's Horizon 2020 research and innovation program [856620]
  2. Instituto de Salud Carlos III (Madrid, Spain) [PI17/02256, PI20/01845]
  3. Consejeria de Economia, Conocimiento, Empresas y Universidad (Granada, Spain) [A-CTS-448-UGR18]
  4. Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (Sevilla, Spain) [PY20/01282]
  5. Generalitat de Catalunya [17SGR437]
  6. Gilead Sciences Fellowship [GLD17/00282]
  7. Xarxa de Bancs de tumors - Pla Director d'Oncologia de Catalunya (XBTC)
  8. Associazione Italiana per la Ricerca sul Cancro
  9. Fondazione Cariplo [TRIDEO 16923, AIRC IG21436]
  10. Spanish Association Against Cancer (AECC) Scientific Foundation grant [GCTRA18022MORE]
  11. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available